Triple-Negative Breast Cancer: Molecular Subtypes; Immune Escape; Limitations of Current Immunotherapy; and the BTLA/HVEM/CD160 Axis as an Emerging Target

Triple-negative breast cancer is an aggressive and heterogeneous type of invasive breast cancer (BC) in which the cancer cells lack estrogen and progesterone receptors, as well as expression of the human epidermal growth factor 2 protein. This cancer tends to grow and spread faster than other BC sub...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bernardo L. Rapoport, Ronald Anderson, Daniel van Tonder, Teresa Smit, Theresa M. Rossouw, Carol-Ann Benn, Helen C. Steel
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-05-01
Colecção:	Current Issues in Molecular Biology
Assuntos:	BTLA CD160 HVEM immune checkpoint proteins immune escape immunotherapy
Acesso em linha:	https://www.mdpi.com/1467-3045/48/5/535
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!